News search

E.g., 01/08/2025
E.g., 01/08/2025
Isabel Gonçalves es profesora y consultora senior en la Universidad de Lund (Suecia)
Research
11 Mar 2025

Isabel Gonçalves is a professor and senior consultant at the University of Lun (Sweden). Her research focuses on cardiovascular disease and diabetes. She is the principal investigator in EXODIAB (Excellence in Diabetes Research in Sweden), leads a team at Cardiovascular Research - Translational Studies, and is a researcher in EpiHealth, a project focused on epidemiology for health.

Carola Vinuesa
About the CNIC
25 Nov 2024

Carola García de Vinuesa is a senior group leader at the Francis Crick Institute in London and the John Curtin School of Medical Research in Canberra.

About the CNIC
18 Nov 2024
Miguel Ángel del Pozo, Jorge Alegre-Cebollada, Carla Huerta-López, Alejandro Clemente-Manteca, Diana Velázquez-Carreras, and Elías Herrero-Galán.
Research
15 Nov 2024

A study by CNIC, published in Science Advances, offers a new approach to understanding how cells respond to mechanical signals from their environment, redefining the comprehension of the relationship between cells and their physical surroundings.

imagen
CNIC researchers
Research
30 Aug 2024

Two studies carried out at the CNIC provide key information about a newly identified cardiovascular risk factor, clonal hematopoiesis, and its treatment with the ancient medication colchicine

Esther Lutgens
Sandro Da Mesquita
Research
6 Jul 2024

Mayo Clinic College of Medicine and Science in Jacksonville

 

Michael P. Snyder
Research
3 Jul 2024

Stanford W. Ascherman Professor of Genetics, Chair of the Genetics Department and Director of the Centre for Genomics and Personalized Medicine at Stanford

About the CNIC
15 May 2024

Globally, cardiovascular diseases due to atherosclerosis – the build-up of plaque in arteries – are the leading cause of death. A new Danish-Spanish research collaboration aims to develop methods to detect atherosclerosis at earlier ages and encourage prevention. Denmark’s Novo Nordisk Foundation has granted up to EUR 23 million to cover the first 2.5 years of the REACT initiative. The initiative is expected to run for 8 years in total